---
title: eXmoor Pharma vs Omniabio
slug_a: exmoorpharma
slug_b: omniabio
site: cdmo
review_signal_gate: closed
canonical_path: /compare/exmoorpharma/omniabio
generated_by: BioBM Editorial AI
---

# eXmoor Pharma vs Omniabio

This comparison is auto-generated by BioBM Editorial AI and intended as an evidence-oriented side-by-side reference.

## Company A

eXmoor Pharma (exmoorpharma) is listed for cdmo. Integrated cell and gene therapy CDMO with 20+ years of consultancy expertise, offering end-to-end CMC support from early-phase strategy through GMP manufacturing across viral vectors, autologous/allogeneic cell therapies, and RNA technologies.

Services: 9. Modalities: 3. Indications: 0. Locations: 1. Certifications: 0. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in services (9).

Review summary: Review summary withheld until site-level review gate opens.

## Company B

Omniabio (omniabio) is listed for cdmo. OmniaBio is a cell and gene therapy CDMO specializing in process development, analytical development, and GMP manufacturing for lentiviral vectors, iPSCs, and immune cell-based therapies. The company operates a 120,000 sq ft facility in Hamilton, Ontario, integrating AI, automation, and robotics to deliver scalable manufacturing from preclinical to commercial stages.

Services: 8. Modalities: 2. Indications: 0. Locations: 1. Certifications: 0. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in services (8).

Review summary: Review summary withheld until site-level review gate opens.